Literature DB >> 18708420

Routine use of oxygen in the treatment of myocardial infarction: systematic review.

M Wijesinghe1, K Perrin, A Ranchord, M Simmonds, M Weatherall, R Beasley.   

Abstract

CONTEXT: International guidelines recommend the routine use of oxygen therapy in the treatment of myocardial infarction (MI).
OBJECTIVE: To undertake a systematic review and meta-analysis of randomised placebo-controlled trials of oxygen therapy in MI. DATA SOURCES: Medline, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, EMBASE and CINHAL. STUDY SELECTION: Randomised placebo-controlled trials of oxygen therapy in MI. DATA EXTRACTION: The primary clinical outcome was mortality.
RESULTS: Two of 51 potential studies met the inclusion criteria. The one study with substantive clinical outcome data reported that in uncomplicated MI, high-flow oxygen was associated with a non-significant increased risk of death (risk ratio 2.9, 95% CI 0.8 to 10.3, p = 0.08) and a greater serum aspartate aminotransferase level (difference 19.2 IU/ml, 95% CI 0 to 38.4, p = 0.05) than room air.
CONCLUSION: The limited evidence that does exist suggests that the routine use of high-flow oxygen in uncomplicated MI may result in a greater infarct size and possibly increase the risk of mortality.

Entities:  

Mesh:

Year:  2008        PMID: 18708420     DOI: 10.1136/hrt.2008.148742

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  34 in total

1.  Hyperoxia during early reperfusion does not increase ischemia/reperfusion injury.

Authors:  Lars Henrik Mariero; Arkady Rutkovskiy; Kåre-Olav Stensløkken; Jarle Vaage
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

2.  Oxygen: when is more the enemy of good?

Authors:  Richard D Branson; Bryce R H Robinson
Journal:  Intensive Care Med       Date:  2010-09-28       Impact factor: 17.440

3.  Human brain blood flow and metabolism during isocapnic hyperoxia: the role of reactive oxygen species.

Authors:  João D Mattos; Monique O Campos; Marcos P Rocha; Daniel E Mansur; Helena N M Rocha; Vinicius P Garcia; Gabriel Batista; Thiago S Alvares; Gustavo V Oliveira; Mônica V Souza; Rogério L R Videira; Natalia G Rocha; Niels H Secher; Antonio C L Nóbrega; Igor A Fernandes
Journal:  J Physiol       Date:  2018-12-26       Impact factor: 5.182

4.  The WHO recommendation for 80% perioperative oxygen is poorly justified.

Authors:  T Volk; J Peters; D I Sessler
Journal:  Anaesthesist       Date:  2017-04       Impact factor: 1.041

5.  Mechanical Ventilation and ARDS in the ED: A Multicenter, Observational, Prospective, Cross-sectional Study.

Authors:  Brian M Fuller; Nicholas M Mohr; Christopher N Miller; Andrew R Deitchman; Brian J Levine; Nicole Castagno; Elizabeth C Hassebroek; Adam Dhedhi; Nicholas Scott-Wittenborn; Edward Grace; Courtney Lehew; Marin H Kollef
Journal:  Chest       Date:  2015-08       Impact factor: 9.410

Review 6.  Emerging roles of thioredoxin cycle enzymes in the central nervous system.

Authors:  A Patenaude; M R V Murthy; M-E Mirault
Journal:  Cell Mol Life Sci       Date:  2005-05       Impact factor: 9.261

7.  Non-invasive cardiac output and oxygen delivery measurement in an infant with critical anemia.

Authors:  Garry M Steil; Olive S Eckstein; Julie Caplow; Michael S D Agus; Brian K Walsh; Jackson Wong
Journal:  J Clin Monit Comput       Date:  2011-06-21       Impact factor: 2.502

Review 8.  [Rational use of oxygen in anesthesiology and intensive care medicine].

Authors:  J Meier; O Habler
Journal:  Anaesthesist       Date:  2011-04       Impact factor: 1.041

Review 9.  Oxygen therapy for acute myocardial infarction.

Authors:  Juan B Cabello; Amanda Burls; José I Emparanza; Susan E Bayliss; Tom Quinn
Journal:  Cochrane Database Syst Rev       Date:  2016-12-19

10.  Concepts in hypoxia reborn.

Authors:  Daniel S Martin; Maryam Khosravi; Mike Pw Grocott; Michael G Mythen
Journal:  Crit Care       Date:  2010-07-30       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.